Should daptomycin–rifampin combinations for MSSA/MRSA isolates be avoided because of antagonism?

Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates

(2015) Claudia Stein et al.   PLoS One

Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE)

(2014) Jonathan A. T. Sandoe et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Relationship ofIn VitroSynergy and Treatment Outcome with Daptomycin plus Rifampin in Patients with Invasive Methicillin-Resistant Staphylococcus aureus Infections

(2013) Warren E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections

(2013) Kheeldass Jugun et al.   INTERNATIONAL ORTHOPAEDICS

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis

(2013) R. Kullar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case–control study

(2012) Y. Achermann et al.   INFECTION

Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus

(2011) Azzam Saleh-Mghir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Successful Salvage of Peritoneal Catheter in Unresolved Methicillin-Resistant Staphylococcus aureus Peritonitis by Combination Treatment with Daptomycin and Rifampin

(2011) Shih-Yi Lin et al.   BLOOD PURIFICATION

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia

(2011) Theodoros Kelesidis et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

(2009) J. M. Miro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia*

(2009) Young Ju Jung et al.   CRITICAL CARE MEDICINE

Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers

(2009) S. Monecke et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index

(2009) K. E. N. Milne et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Experience with Daptomycin for the Treatment of Patients with Documented Gram-Positive Septic Arthritis

(2008) Graeme N Forrest et al.   ANNALS OF PHARMACOTHERAPY